Autonomix Medical (NASDAQ:AMIX) Announces Earnings Results

Autonomix Medical (NASDAQ:AMIX) released its quarterly earnings data on Wednesday. The company reported $0.09 earnings per share for the quarter, FiscalAI reports.

Autonomix Medical Price Performance

AMIX opened at $0.42 on Friday. The company has a fifty day moving average price of $0.38 and a 200-day moving average price of $0.51. The firm has a market capitalization of $2.87 million, a P/E ratio of -0.12 and a beta of -1.82. Autonomix Medical has a one year low of $0.20 and a one year high of $2.64.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Maxim Group reduced their price objective on shares of Autonomix Medical from $5.00 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, February 17th. Weiss Ratings upgraded shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $2.00.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.